SCLX News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

SC

Mkt Cap

$19.9M

Volume

28.61K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLPScilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million strategic investment at $15 per share (approximately 6.67 million shares). The investment will support Scilex's growth initiatives including product development, commercialization, acquisitions, and strategic partnerships. The deal remains subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory clearances.GlobeNewswire Inc. · Jul 6, 2026

Scilex (SCLX) Stock Jumps After Dream Bowl Meme Coin Listing Update: Why Is It Moving?Scilex Holding Company shares surged 18.79% after announcing that its Dream Bowl I Meme Coin tokens will begin trading on Biconomy Exchange as early as June 23. The listing is expected to improve liquidity and enable broader distribution for eligible token holders. Scilex is a biotech company focused on non-opioid pain management products.Benzinga · Jun 17, 2026

Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity SecuritiesScilex Holding Company announced that its board has set June 15, 2026 as the payment date for a dividend of Semnur Pharmaceuticals common stock to Scilex shareholders. The company plans to distribute approximately 14.0 million shares of Semnur (out of 186 million owned) on a 1:1 basis for each Scilex share held as of the June 1, 2026 record date. The dividend is subject to board revocation if there are material changes to solvency or surplus analysis.Benzinga · Jun 4, 2026

Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026Scilex Holding Company's board approved a dividend distribution of Semnur Pharmaceuticals common stock to its shareholders, with a record date of June 1, 2026. Scilex will distribute approximately 10.7 million shares of its ~186 million Semnur holdings to eligible equity holders at a 1:1 ratio. The payment date will be determined by subsequent board resolutions within 60 days of the record date, though the board retains the right to change the record date or revoke the dividend.Benzinga · May 22, 2026

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedScilex Holding Company announced that its subsidiaries ACEA Therapeutics and ACEA Pharma entered into a definitive agreement to sell 100% of ACEA Pharma's equity to Phoenix Asia Holdings Limited for $1 billion in newly-issued shares. Upon closing, Phoenix will be renamed ACEA Pharma and listed on Nasdaq, with ACEA Thera retaining approximately 82% ownership. The transaction is expected to close by end of Q2 2026, subject to regulatory and stock exchange approvals.GlobeNewswire Inc. · May 5, 2026

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedScilex Holding Company's subsidiaries ACEA Therapeutics and ACEA Pharma have entered into a definitive stock acquisition agreement with Phoenix Asia Holdings Limited. Under the deal, ACEA will transfer 100% of ACEA Pharma's equity to Phoenix in exchange for 100 million newly-issued ordinary shares at $10 per share, valuing the transaction at $1 billion. Upon closing, Phoenix will be renamed ACEA Pharma, Inc. and its stock is expected to list on Nasdaq. The transaction is expected to close by end of Q2 2026, subject to regulatory approvals.Benzinga · May 5, 2026

Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026Scilex Holding Company's board approved May 26, 2026 as the payment date for distributing approximately 81.4 million Dream Bowl Meme Coin I tokens to shareholders, with a record date of April 30, 2026. Shareholders will receive 5 tokens per share of common stock. The company plans to list the tokens on the Biconomy cryptocurrency exchange in Q2 2026. The dividend is explicitly stated to have no investment value and is conditioned on the board not revoking it prior to payment.GlobeNewswire Inc. · May 4, 2026

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis MarketsScilex Holding Company (Nasdaq: SCLX) announced a $20 million strategic investment in Quantum Scan Holdings, Inc., a medical technology company focused on preventive diagnosis and prognosis. The investment aims to support Quantum Scan's development of advanced diagnostic platforms and healthcare solutions. Scilex views this investment as synergistic with its existing investment in Datavault AI and aligned with its strategic priorities in advancing healthcare solutions.GlobeNewswire Inc. · Jan 30, 2026

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend PaymentsOramed Pharmaceuticals received an $18 million payment from Scilex Holdings, closing out option agreement obligations and bringing total returns to $118 million on its original $99.5 million investment. The company's board approved a $0.25 per share cash dividend (~$10.5 million aggregate) to be paid on January 26, 2026. Oramed retains $39 million in outstanding debt, convertible notes, warrants, and royalty interests with Scilex.Benzinga · Jan 7, 2026

Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property CounselScilex Holding Company announced the appointment of Kasowitz LLP and founding partner Marc Kasowitz as its litigation and intellectual property counsel. The firm will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, and strategic IP governance as the company advances its pharmaceutical assets and development pipeline.GlobeNewswire Inc. · Jan 2, 2026

SC

SCLXScilex Holding Company Common Stock

SCLX

Pay with—

Available Balance0.00

Your PositionYou don't own any SCLX yet.

Related Tickers

Earnings